Hexagon Capital Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Hexagon Capital Partners's NVS Position: Q1 2026 in Review
Hexagon Capital Partners opened a new position in Novartis (NVS) in Q1 2026: 3,783 shares worth $578K. The stake represents 0.08% of the portfolio and ranks #101 among its holdings. This is a return to the name: Hexagon Capital Partners previously reported a position in NVS as recently as Q1 2025.
Hexagon Capital Partners first reported a position in NVS in Q3 2020 and has held it in 20 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Hexagon Capital Partners held 3,783 shares of Novartis worth $578K as of Q1 2026.
- Novartis was a new Hexagon Capital Partners position in Q1 2026.
- Novartis made up 0.08% of Hexagon Capital Partners's portfolio in Q1 2026, its #101 holding.
- Hexagon Capital Partners first reported a position in Novartis in Q3 2020 and has held it in 20 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Hexagon Capital Partners's 13F filing for Q1 2026, filed 5 May 2026.